Beta Bionics, Inc.
BBNXNASDAQHealthcare● Active
$13.87
$-0.02(-0.14%)
Market Cap$618070710
P/E Ratio—
52W High$32.71
52W Low$8.8
Beta Bionics, Inc. (BBNX) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · BBNX · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 |
|---|---|---|---|---|
| Revenue | ||||
| Revenue | $0.10B | $0.07B | $0.01B | $0.00B |
| Cost of Revenue | $0.04B | $0.03B | $0.01B | $0.00B |
| Gross Profit | $0.06B | $0.04B | $0.01B | $0.00B |
| Gross Margin %(computed) | 55.40% | 55.11% | 52.59% | 100.00% |
| Operating Expenses | ||||
| R&D Expenses | $0.03B | $0.03B | $0.02B | $0.03B |
| G&A Expenses | $0.03B | $0.02B | $0.01B | $0.02B |
| Total Operating Expenses | $0.13B | $0.08B | $0.04B | $0.07B |
| Operating Income | ($0.07B) | ($0.05B) | ($0.04B) | ($0.07B) |
| Operating Margin %(computed) | -71.50% | -69.48% | -298.87% | — |
| Interest Income | $0.01B | $0.00B | $0.00B | $0.00B |
| Interest Expense | $0.00B | $0.00B | $0.00B | $0.00B |
| Income Before Tax | ($0.07B) | ($0.05B) | ($0.04B) | ($0.06B) |
| Income Tax Expense | $0.00B | $0.00B | $0.00B | $0.00B |
| Net Income | ($0.07B) | ($0.05B) | ($0.04B) | ($0.06B) |
| Net Margin %(computed) | -73.02% | -84.08% | -367.64% | — |
| Per Share & EBITDA | ||||
| EPS (Basic) | $-1.81 | $-8.60 | $-8.31 | $-12.96 |
| Wtd Avg Shares | 0.04B | 0.01B | 0.01B | 0.00B |
| EBITDA | ($0.07B) | ($0.04B) | ($0.03B) | ($0.06B) |
| EBITDA Margin %(computed) | -73.02% | -67.72% | -288.65% | — |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · B
Explore more Beta Bionics, Inc. data
About Beta Bionics, Inc. (BBNX) Income Statement
Beta Bionics, Inc. (BBNX) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, BBNX reported revenue of $0.10B, gross profit of $0.06B (gross margin 55.40%), and net income of ($0.07B) — a net profit margin of -73.02%.
Frequently asked questions
BBNX · 4 questionsBeta Bionics, Inc. (BBNX) reported revenue of $0.10B for 2025, up 53.9% year-over-year.
BBNX revenueBBNX salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08